Mostrar el registro sencillo del ítem

dc.contributor.authorMalik, V.
dc.contributor.authorZang, R.
dc.contributor.authorFuentes-Iglesias, A.
dc.contributor.authorHuang, X.
dc.contributor.authorLi, D.
dc.contributor.authorFidalgo Pérez, Miguel Ángel
dc.contributor.authorZhou, H.
dc.contributor.authorWang, J.
dc.date.accessioned2025-08-26T09:34:15Z
dc.date.available2025-08-26T09:34:15Z
dc.date.issued2022
dc.identifier.citationMalik V, Zang R, Fuentes-Iglesias A, Huang X, Li D, Fidalgo M, et al. Comparative functional genomics identifies unique molecular features of EPSCs. Life Science Alliance. 2022;5(11).
dc.identifier.issn2575-1077
dc.identifier.otherhttps://portalcientifico.sergas.gal/documentos/631ce8fd63e72b10525637ae*
dc.identifier.urihttp://hdl.handle.net/20.500.11940/20691
dc.description.abstractExtended pluripotent or expanded potential stem cells (EPSCs) possess superior developmental potential to embryonic stem cells (ESCs). However, the molecular underpinning of EPSC maintenance in vitro is not well defined. We comparatively studied transcriptome, chromatin accessibility, active histone modification marks, and relative proteomes of ESCs and the two well-established EPSC lines to probe the molecular foundation underlying EPSC developmental potential. Despite some overlapping transcriptomic and chromatin accessibility features, we defined sets of molecular signatures that distinguish EPSCs from ESCs in transcriptional and translational regulation as well as metabolic control. Interestingly, EPSCs show similar reliance on pluripotency factors Oct4, Sox2, and Nanog for self-renewal as ESCs. Our study provides a rich resource for dissecting the regulatory network that governs the developmental potency of EPSCs and exploring alternative strategies to capture totipotent stem cells in culture.en
dc.description.sponsorshipWe thank Drs. Amander T Clark, Richard A Young, Austin Smith, and Hitoshi Niwa for providing Tfap2a/c dKO, Oct4-degron ESCs, ZHBTC4 ESCs, and 2TS22C ESCs, respectively. This work in the Wang laboratory is funded by grants from the National Institutes of Health (R01HD095938 and R01HD097268) and by contracts from New York State Stem Cell Science (NYSTEM#C35583GG). A Fuentes-Iglesias is the recipient of a fellowship from the MINECO of Spain (BES-2017-082007).en
dc.language.isoeng
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleComparative functional genomics identifies unique molecular features of EPSCs*
dc.typeArticleen
dc.authorsophosMalik, J. V.
dc.authorsophosZang, R.
dc.authorsophosFuentes-Iglesias, A.
dc.authorsophosHuang, X.
dc.authorsophosLi, D.
dc.authorsophosFidalgo, M.
dc.authorsophosZhou, H.
dc.authorsophosWang
dc.identifier.doi10.26508/lsa.202201608
dc.identifier.sophos631ce8fd63e72b10525637ae
dc.issue.number11
dc.journal.titleLife Science Alliance*
dc.relation.projectIDNational Institutes of Health [R01HD095938, R01HD097268]; New York State Stem Cell Science (NYSTEM) [C35583GG]; MINECO of Spain [BES-2017-082007]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD095938, R01HD097268] Funding Source: NIH RePORTER
dc.relation.publisherversionhttps://www.life-science-alliance.org/content/lsa/5/11/e202201608.full.pdfes
dc.rights.accessRightsopenAccess
dc.subject.keywordAS Santiagoes
dc.subject.keywordIDISes
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)es
dc.typesophosArtículo Originales
dc.volume.number5


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional